David Albiani

Dr. David Albiani, BSc, MD, EMBA, FRCSC

Clinical Assistant Professor & Division Head


Basic Info


Bachelor of Science (Queen’s University)

Doctor of Medicine (Queen’s University)

Residency, Ophthalmology (University of Ottawa)

Fellowship, Diseases and Surgery of the Retina and Vitreous (University of British Columbia)

Executive Master’s in Business Administration (University of British Columbia)

Board Certification

Royal College of Physicians and Surgeons of Canada



Dr. David Albiani is a clinical associate professor with the University of British Columbia’s Ophthalmology Department. He obtained an undergraduate Life Science degree and attended medical school at Queen’s University in Kingston, Ontario. He then did ophthalmology residency at the University of Ottawa Eye Institute. Following his residency, he did his fellowship training in medical and surgical retina at the University of British Columbia. He also obtained his Executive Master’s in Business Administration from the UBC Sauder School of Business.

Dr. Albiani’s clinical expertise and research interests include age-related macular degeneration, diabetic retinopathy, retinal detachment, surgical macular disorders and complicated lens surgery.

Dr. Albiani is the current Head, Retina Division at UBC and Department Head of Ophthalmology at Providence Health Care.  He is the current Chair, PHC Medical Advisory Committee.  He has served as Director of the UBC Vitreoretinal Surgery Fellowship, member of the Provincial Surgical Executive Committee and President of the British Columbia Society of Eye Physicians and Surgeons in the past.



Currently Recruiting Clinical Trials

A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration

A Phase 3 Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista (anti-PDGF-B pegylated aptamer) Administered in Combination with Either Avastin or Eylea Compared to Avastin or Eylea Monotherapy in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration

Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity (Diabetic Retinopathy Clinical Research Network)

Peripheral Diabetic Retinopathy Lesions on Ultrawide-Field Fundus Images and Risk of Diabetic Retinopathy Worsening Over Time (Diabetic Retinopathy Clinical Research Network)

A Phase 3 Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista (anti-PDGF-B pegylated aptamer) Administered in Combination with Lucentis Compared to Lucentis Monotherapy in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration


Lam WC, Albiani DA, Yoganathan P, Chen JC, Kherani A, Maberley DA, Oliver A, Rabinovitch T, Sheidow TG, Tourville E, Wittenberg LA, Sigouin C, Baptiste DC. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol. 2015 Jul 10;9:1255-68.

Tan PE, Balaratnasingam C, Xu J, Mammo Z, Han SX, Mackenzie P, Kirker AW, Albiani D, Merkur AB, Sarunic MV, Yu DY. Quantitative Comparison of Retinal Capillary Images Derived By Speckle Variance Optical Coherence Tomography With Histology. Invest Ophthalmol Vis Sci. 2015 Jun 1;56(6):3989-96.

Chan G, Balaratnasingam C, Xu J, Mammo Z, Han S, Mackenzie P, Merkur A, Kirker A, Albiani D, Sarunic MV, Yu DY. In vivo optical imaging of human retinal capillary networks using speckle variance optical coherence tomography with quantitative clinico-histological correlation. Microvasc Res. 2015 Jul;100:32-9.

Xu J, Han S, Balaratnasingam C, Mammo Z, Wong KS, Lee S, Cua M, Young M, Kirker A, Albiani D, Forooghian F, Mackenzie P, Merkur A, Yu DY, Sarunic MV. Retinal angiography with real-time speckle variance optical coherence tomography. Br J Ophthalmol. 2015 Mar 2.

Pakzad-Vaezi K, Albiani DA, Kirker AW, Merkur AB, Kertes PJ, Eng KT, Fallah N, Forooghian F. A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):521-4.

Nathoo NA, Or C, Young M, Chui L, Fallah N, Kirker AW, Albiani DA, Merkur AB, Forooghian F. Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration.  Am J Ophthalmol. 2014 Oct;158(4):757-761.

Young M, Chui L, Fallah N, Or C, Merkur AB, Kirker AW, Albiani DA, Forooghian F. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.  Retina. 2014 Jul;34(7):1308-15.

Ding W, Young M, Bourgault S, Lee S, Albiani DA, Kirker AW, Forooghian F, Sarunic MV, Merkur AB, Beg MF. Automatic detection of subretinal fluid and sub-retinal pigment epithelium fluid in optical coherence tomography images. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:7388-91.

Cao S, Ko A, Partanen M, Pakzad-Vaezi K, Merkur AB, Albiani DA, Kirker AW, Wang A, Cui JZ, Forooghian F, Matsubara JA. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmol. 2013 Dec;156(6):1176-83

Forooghian F, Maberley D, Albiani DA, Kirker AW, Merkur AB, Etminan M. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study. Ocul Immunol Inflamm. 2013 Oct;21(5):390-3.

Bourgault S, Albiani D. Re: Split Ozurdex implant: a caution. Can J Ophthalmol. 2013 Jun;48(3):218-9.

Lee S, Fallah N, Forooghian F, Ko A, Pakzad-Vaezi K, Merkur AB, Kirker AW, Albiani DA, Young M, Sarunic MV, Beg MF. Comparative analysis of repeatability of manual and automated choroidal thickness measurements in nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013 Apr 23;54(4):2864-71.

Ko A, Cao S, Pakzad-Vaezi K, Brasher PM, Merkur AB, Albiani DA, Kirker AW, Cui J, Matsubara J, Forooghian F. Optical coherence tomography-based correlation between choroidal thickness and drusen load in dry age-related macular degeneration. Retina. 2013 May;33(5):1005-10.

Butler AL, Fung AT, Merkur AB, Albiani DA, Forooghian F. Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy. Can J Ophthalmol. 2012 Feb;47(1):42-4.

Seth A, Anderson DP, Albiani DA, Barton JJ. Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer. Can J Ophthalmol. 2009 Aug;44(4):467-8.

Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN. Tranexamic acid in the treatment of pediatric traumatic hyphema. Can J Ophthalmol. 2008 Aug;43(4):428-31.

Hodge W, Horsley T, Albiani D, Baryla J, Belliveau M, Buhrmann R, O’Connor M, Blair J, Lowcock E. The consequences of waiting for cataract surgery: a systematic review. CMAJ. 2007 Apr 24;176(9):1285-90. Review.

Al-Ghamdi A, Albiani DA, Hodge WG, Clarke WN. Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation. Can J Ophthalmol. 2004 Aug;39(5):521-5.

Arshinoff SA, Albiani DA, Taylor-Laporte J. Intraocular pressure after bilateral cataract surgery using Healon, Healon5, and Healon GV. J Cataract Refract Surg. 2002 Apr;28(4):617-25.

Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown M, Cruess AF, Sharma S. Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol. 2001 Jun;36(4):202-9.